1-1 of 1
Mizuki Aimoto, MD PhD
Close
Sort by
Journal Articles

Azacitidine (AZA) Combination Therapy with Low-Dose AraC for Aggressive Type MDS, Overt AML, and AML Patients

Manabu Hirai, MDPhD, Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Mizuki Aimoto, MD PhD, Erina Sakamoto, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1688.
https://doi.org/10.1182/blood.V126.23.1688.1688
Published: 2015